With masking and vaccinations, schools were not major COVID-19 transmittors, review finds

The findings of a two-year review provide a strong foundation on how to properly deal with significant outbreaks caused by future variants or other infectious diseases.

By Adam Ward, Faculty of Health Sciences February 16, 2024

A group of school-age children wearing masks in the classrooml.
When infection prevention and control measures were used, schools and daycares weren’t a major source of COVID-19 transmission, an extensive review by McMaster researchers has found. (Shutterstock image)

Expert Featured In This Story

Sarah Neil-Sztramko
Sarah Neil-Sztramko

Assistant Professor

See Profile

When infection prevention and control measures were used, schools and daycares weren’t a major source of COVID-19 transmission, an extensive review by McMaster researchers has found.

The final living rapid review, published Feb. 15 in The Lancet Child and Adolescent Health, marks the culmination of the work by members of the National Collaborating Centre for Methods and Tools (NCCMT) that started in May 2020.

The NCCMT is one of six national collaborating centres for public health in Canada.

The review, initially completed in May 2020, was updated 18 times, with the final update conducted at the end of 2022.

More than 34,000 references, including databases and websites, were screened as part of these reviews.

“We found that after that initial shutdown where everything was locked down, schools did not appear to have much impact on community level transmission when infection prevention control measures were in place,” said lead author and researcher Sarah Neil-Sztramko, who is also an assistant professor in the department of Health Research Methods, Evidence and Impact in the Faculty of Health Sciences.

Masking, vaccinations and test-to-stay policies were the most effective at mitigating COVID-19’s spread in schools and daycares.

Test-to-stay allowed children who tested negative after a confirmed case in a class to still attend school instead of everyone being part of a two-week quarantine at home.

“It is important to understand which measures mitigate transmission so that schools can remain open as much as possible, given the negative impacts that were found during COVID-19 when they were closed,” said Neik-Sztramko.

“If there were to be another wave where community transmission was increasing and straining the health-care system, strategies such as masking, vaccination, and test-to-stay interventions are effective in fighting transmission, allowing schools to stay open.”

The living rapid review was continuously updated over two years as new data and studies became available. Researchers previously noted that children under the age of 10 were less likely to drive COVID-19 outbreaks in daycares and schools.

“We were also able to learn what measures were most important when people were vaccinated, and we continued to learn what worked as new evidence emerged throughout the pandemic,” Neil-Sztramko said.

While many of the measures highlighted as effective in curbing COVID-19’s spread are no longer used en masse, Neil-Sztramko believes the findings provide a strong and factual foundation on how to properly deal with significant outbreaks caused by future variants or other infectious diseases.

The NCCMT is hosted by McMaster and funded by the Public Health Agency of Canada (PHAC). The agency had no role in the design, conduct or analysis of the data. PHAC also provided funding to NCCMT to conduct this study.

A close-up of a vial containing a clear peptide blend of BPC-157 and TB-500, next to two single-use syringes.

What do we know about ‘research only’ peptides? Q&A with expert Stuart Phillips 

Unapproved peptides that lack safety and efficacy data carry substantial risks and belong in a laboratory, not your body, Phillips warns.
Scientist Jon Stokes stands in a university corridor, wearing a hoodie and ball cap.

McMaster researcher awarded more than $2M from Weston Family Foundation to advance precision antibiotic for IBD

The funding will accelerate the move toward human trials, enabling preclinical studies, regulatory preparation and early-phase clinical trial design.
?A stent being held by a clinician wearing gloves.

Minimally invasive procedure offers new hope for patients with complications from blood clots

Patients who had the procedure experienced a significantly better quality of life and less severe post-thrombotic syndrome, a painful condition that affects 20 to 50 per cent of people who had a deep vein thrombosis.